CoChat

Proton pump inhibitors and risk of hearing loss; a systematic review

Khadivi, Amin, Amiri, Fatemeh, Radnia, Parastoo, Salehi-pourmehr, Hanieh, Mirzaei Bavil, Fariba, Pakkhesal, Sina, Hamzehzadeh, Sina, Moghaddam, Yalda Jabbari, Naseri, Amirreza · 2025 · Naunyn-Schmiedeberg's Archives of Pharmacology

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Proton pump inhibitors (PPIs) are widely used medications for the treatment of gastroesophageal reflux disease (GERD) and other conditions requiring acid suppression. While generally considered safe, concerns have emerged regarding potential long-term adverse effects of PPIs, such as ototoxicity. To systematically synthesize the evidence regarding the association between PPIs usage and the risk of hearing loss. This systematic review followed PRISMA guidelines. PubMed/Medline, Embase, Scopus, and Web of Science databases were searched in May 2024 and further updated using a handsearching in December 2024. Clinical original studies evaluating the relationship between PPI usage and any type of hearing impairments were included. Exclusion criteria include non-human studies, non-English language publications, reviews, case reports, book chapters, conference abstracts, and retracted studies. Risk of bias was assessed using the Joanna Briggs Institute (JBI) critical appraisal tools. The initial database search yielded 661 records. Four studies (total n = 208,956 participants) proceeded to full-text review and were included in the qualitative synthesis. All of the included studies demonstrated a statistically significant association between PPI use and an increased risk of hearing impairments; even after adjusting for possible confounders; however, one study found no independent association after adjusting for GERD symptoms. The findings of this systematic review reveal inconclusive results regarding the association between PPI use and hearing loss. While the limited available evidence suggests a possible increased risk, further research is needed to dissect the possible causal relationship and elucidate the underlying mechanisms.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00210-025-04241-5

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 67 references

Research works printed but not linked: 2

  1. Makhoul E, Waked H (2018) Proton pump inhibitor use and vitamin B12 deficiency in a lebanese population. Int J Dev Res 08:4
  2. Moola S, Munn Z, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K (2017) Chapter 7: Systematic reviews of etiology and risk. Joanna briggs institute reviewer’s manual. The Joanna Briggs Institute 5:217–269

Metadata

Authors
Khadivi, A., Amiri, F., Radnia, P., Salehi-pourmehr, H., Mirzaei Bavil, F., Pakkhesal, S., Hamzehzadeh, S., Moghaddam, Y. J., & Naseri, A.
Affiliations
Tabriz University of Medical Sciences (IR)
Corresponding author
  • Moghaddam, Yalda Jabbari
  • Naseri, Amirreza
Venue
Naunyn-Schmiedeberg's Archives of Pharmacology
Published
2025-05-09
Volume
398
Issue
10
Pages
13567-13580
ISSN
  • 0028-1298 (ISSN-L)
  • 1432-1912
OpenAlex
W4410240970
Cited by
2
References
67
Citations by year
2026: 2
FWCI
0.30
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Tabriz University of Medical Sciences (74439)
Topics
  • Life Sciences › Neuroscience › Sensory Systems › Hearing, Cochlea, Tinnitus, Genetics
  • Health Sciences › Health Professions › Speech and Hearing › Hearing Loss and Rehabilitation
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
Keywords
proton pump inhibitors, hearing loss, ototoxicity, gastroesophageal reflux disease, acid suppression, adverse drug reactions, chronic drug administration
MeSH terms
Gastroesophageal Reflux, Humans, Risk Factors, Hearing Loss, Proton Pump Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Proton pump inhibitors and risk of hearing loss; a systematic review. https://app.cochat.ai/papers/10.1007/s00210-025-04241-5
The paper
Khadivi, A., Amiri, F., Radnia, P., Salehi-pourmehr, H., Mirzaei Bavil, F., Pakkhesal, S., Hamzehzadeh, S., Moghaddam, Y. J., & Naseri, A. (2025). Proton pump inhibitors and risk of hearing loss; a systematic review. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-025-04241-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.